By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

It was specifically designed to minimize engagement with central nervous system pathways implicated in the psychiatric side effects observed in some smoking cessation therapies and first-generation ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...